NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, reported preliminary unaudited results for its fourth quarter and ...
NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, announced that a select group of private investors and family ...
NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has been invited to present at H.C. Wainwright’s BioConnect Conference ...
Conversion Labs Pays off All Convertible Debt in Preparation for Growth and Market Expansion in 2020
NEW YORK, March 02, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has paid off all of its outstanding convertible notes totaling ...
NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB:CVLB) (the “Company” or “Conversion Labs”), an e-commerce company focused on creating, acquiring and scaling proprietary ...
Conversion Labs was highlighted in a bull call by Citron Research. The company is building a DTC health and wellness platform focused on subscription services. Q4 revenues surged 265% to $13.6 million ...
NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has completed its previously announced equity investment by a ...
NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has closed on approximately $14.5 million of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results